• Institute of Clinical Medicine Research, the First People’s Hospital of Foshan, Foshan 528000, China;
ZENG Jinwei, Email: zjwei@fsyyy.com
Export PDF Favorites Scan Get Citation

Objective  To determine the best threshold value of hemoglobin A2 (HbA2) for diagnosis of β-thalassemia (β-thal) carriers by using high performance liquid chromatography (HPLC), and to improve the application value of HbA2 as a diagnostic index for β-thal carriers to reduce the rates of missed diagnosis and misdiagnosis.
Methods  Using reverse dot blot (RDB) as a gold standard method, HbA2 results of 1 007 β-thal carriers and 606 normal controls in the past two years determined by HPLC were divided into true positive, false positive, true negative, and false negative based on the different threshold values of HbA2 results. Then, the evaluation indexes such as sensitivity, specificity, positive and negative likelihood ratio, and Youden’s index were evaluated. Next, the receiver operator characteristic (ROC) curve was drawn to determine the best threshold value of HbA2 for diagnosis of β-thal carriers by HPLC.
Results  If ≥4.0% was taken as the threshold value of HbA2 for diagnosis of β-thal carriers by HPLC, the evaluation indexes values were shown as follows: sensitivity 99.21%, specificity 99.34%, positive likelihood ratio 150.30, negative likelihood ratio 0.008, and Youden’s index 0.99. The Youden’s index was better than the other threshold values, and the corresponding tangent point was the peak point of the ROC curve.
Conclusion  When ≥4.0% serves as the best threshold value of HbA2 for diagnosis of β-thal carriers using HPLC, integrated evaluation performance of the corresponding sensitivity and specificity is the most ideal, and the authenticity of the diagnostic test is the best.

Citation: ZENG Jinwei,YANG Guang,CUI Jinhuan,TANG Lixia,QU Liqun. The Best Threshold Value of Hemoglobin A2 for Diagnosis of β-Thalassemia Carriers by High Performance Liquid Chromatography. Chinese Journal of Evidence-Based Medicine, 2009, 09(8): 828-831. doi: 10.7507/1672-2531.20090146 Copy

  • Previous Article

    Effects of PTD versus TD Regimens for Multiple Myeloma: A Randomized Controlled Trial
  • Next Article

    Maternal and Obstetrical Outcomes of Birth in Water: A Systematic Review